Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Distraction Methods for Trigger Finger Injection Pain
NCT03445780Phase 1Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Jun 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ethyl chloride in trigger finger (4 arms), sponsored by NYU Langone Health. Primary endpoint: Visual Analog Scale at 24 hours. Planned start Jun 2019; status: withdrawn.
02
Drugs
ethyl chloride
03
Conditions
trigger finger
Beyond the preview
Go deeper on NCT03445780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03445780.